translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
UNITED STATES: Federal Appeals Court Blocks Teva from Selling
September 10, 2007
New York Times (09.08.07) - Monday, September 10, 2007

On Friday, Teva Pharmaceuticals announced that a federal appeals court had temporarily enjoined the firm from selling the generic drug famciclovir, which is used to treat herpes, cold sores, and shingles. The injunction will remain in effect until an emergency motion for a stay filed by Novartis, which contends it holds patents for Famvir (famciclovir) valid until 2015, can be considered. A Federal District Court in Newark had previously denied Novartis a preliminary injunction, allowing Teva to introduce the generic to US consumers. The two companies have been in patent infringement litigation since 2005.